NanoViricides, Inc.

8-K Entered a material agreement; Other events Jul 30, 2026 8-K Entered a material agreement Jul 17, 2026 8-K Regulation FD disclosure May 21, 2026 8-K Entered a material agreement; Other events May 20, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-Q Quarter ended 2025-12-31 Feb 17, 2026 8-K Shareholder vote results Nov 26, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Oct 1, 2025 10-K Fiscal year ended 2025-06-30 Sep 29, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K Shareholder vote results Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 10-K Fiscal year ended 2024-06-30 Sep 27, 2024 8-K Director or officer change Aug 9, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Entered a material agreement Apr 5, 2024 8-K Entered a material agreement Feb 16, 2024 10-Q Quarter ended 2023-12-31 Feb 14, 2024 8-K Shareholder vote results Jan 19, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Other events Nov 7, 2023 10-K Fiscal year ended 2023-06-30 Oct 13, 2023 8-K Entered a material agreement; Took on a direct financial obligation Sep 1, 2023 8-K Other events May 25, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 8-K Entered a material agreement Mar 31, 2023 10-Q Quarter ended 2022-12-31 Feb 14, 2023 8-K Shareholder vote results Feb 13, 2023 8-K Shareholder vote results; Other events Dec 22, 2022 10-Q Quarter ended 2022-09-30 Nov 14, 2022 10-K Fiscal year ended 2022-06-30 Oct 13, 2022 8-K Director or officer change Oct 11, 2022 10-Q Quarter ended 2022-03-31 May 16, 2022 10-Q Quarter ended 2021-12-31 Feb 14, 2022 8-K Shareholder vote results Nov 26, 2021 10-Q Quarter ended 2021-09-30 Nov 15, 2021 10-K Fiscal year ended 2021-06-30 Oct 12, 2021